Boothbay Fund Management »

Centessa Pharmaceuticals shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.3M 136k 24.25
2025-06-30 $1.5M 114k 13.14
2025-03-31 $603k 42k 14.38
2024-12-31 $702k 42k 16.75

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Gbl Comm Svc Etf Put Option (IXP)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A (PLTR)
Alphabet Cap Stk Cl C Call Option (GOOG)
Amazon Call Option (AMZN)
Select Sector Spdr Tr Indl Put Option (XLI)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Broadcom (AVGO)
Cornerstone Strategic Value (CLM)
Advanced Micro Devices Call Option (AMD)
Apple Call Option (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Centessa Pharmaceuticals

Medicxi Ventures Management
venBio Select Advisor
Adage Capital Partners GP
General Atlantic
FMR
Henderson Group
Farallon Capital Management
First Light Asset Management
Siren
TCG Crossover Management
Perceptive Advisors
Commodore Capital
Franklin Resources
Rtw Investments
Cormorant Asset Management

View all funds holding Centessa Pharmaceuticals